Literature DB >> 18495759

Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding.

Juan Cardenas-Mora1, Jonathan E Spindler, Moon Kyoo Jang, Alison A McBride.   

Abstract

The E2 proteins of several papillomaviruses link the viral genome to mitotic chromosomes to ensure retention and the efficient partitioning of genomes into daughter cells following cell division. Bovine papillomavirus type 1 E2 binds to chromosomes in a complex with Brd4, a cellular bromodomain protein. Interaction with Brd4 is also important for E2-mediated transcriptional regulation. The transactivation domain of E2 is crucial for interaction with the Brd4 protein; proteins lacking or mutated in this domain do not interact with Brd4. However, we found that the C-terminal DNA binding/dimerization domain of E2 is also required for efficient binding to Brd4. Mutations that eliminated the DNA binding function of E2 had no effect on the ability of E2 to interact with Brd4, but an E2 protein with a mutation that disrupted C-terminal dimerization bound Brd4 with greatly reduced efficiency. Furthermore, E2 proteins in which the C-terminal domains were replaced with the dimeric DNA binding domain of EBNA-1 or Gal4 bound efficiently to the Brd4 protein, but the replacement of the E2 C-terminal domain with a monomeric red fluorescent protein did not rescue efficient Brd4 binding. Thus, E2 bound to Brd4 most efficiently as a dimer. To prove this finding further, the E2 DNA binding domain was replaced with an FKBP12-derived domain in which dimerization was regulated by a bivalent ligand. This fusion protein bound Brd4 efficiently only in the presence of the ligand, confirming that a dimer of E2 was required. Correspondingly, E2 proteins that could dimerize were able to bind to mitotic chromosomes much more efficiently than monomeric E2 polypeptides.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495759      PMCID: PMC2493320          DOI: 10.1128/JVI.00772-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition.

Authors:  A Dey; J Ellenberg; A Farina; A E Coleman; T Maruyama; S Sciortino; J Lippincott-Schwartz; K Ozato
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.

Authors:  Anup Dey; Farideh Chitsaz; Asim Abbasi; Tom Misteli; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

3.  Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes.

Authors:  Jianxin You; Jennie L Croyle; Akiko Nishimura; Keiko Ozato; Peter M Howley
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

4.  Brd4 links chromatin targeting to HPV transcriptional silencing.

Authors:  Shwu-Yuan Wu; A-Young Lee; Samuel Y Hou; Jongsook Kim Kemper; Hediye Erdjument-Bromage; Paul Tempst; Cheng-Ming Chiang
Journal:  Genes Dev       Date:  2006-08-18       Impact factor: 11.361

5.  The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops.

Authors:  J D Knight; R Li; M Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA.

Authors:  E J Androphy; D R Lowy; J T Schiller
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

7.  Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number.

Authors:  K J Penrose; A A McBride
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain.

Authors:  A A McBride; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

9.  Structure of the intact transactivation domain of the human papillomavirus E2 protein.

Authors:  A A Antson; J E Burns; O V Moroz; D J Scott; C M Sanders; I B Bronstein; G G Dodson; K S Wilson; N J Maitland
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

10.  Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor.

Authors:  Yong Wang; René Coulombe; Dale R Cameron; Louise Thauvette; Marie-Josée Massariol; Lynn M Amon; Dominique Fink; Steve Titolo; Ewald Welchner; Christiane Yoakim; Jacques Archambault; Peter W White
Journal:  J Biol Chem       Date:  2003-11-22       Impact factor: 5.157

View more
  19 in total

Review 1.  Hitchhiking on host chromatin: how papillomaviruses persist.

Authors:  Alison A McBride; Nozomi Sakakibara; Wesley H Stepp; Moon Kyoo Jang
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 2.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

3.  The SMC5/6 Complex Interacts with the Papillomavirus E2 Protein and Influences Maintenance of Viral Episomal DNA.

Authors:  Peris Bentley; Min Jie Alvin Tan; Alison A McBride; Elizabeth A White; Peter M Howley
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 4.  Hitchhiking of Viral Genomes on Cellular Chromosomes.

Authors:  Tami L Coursey; Alison A McBride
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

5.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Authors:  Sophie Bellanger; Chye Ling Tan; Yue Zhen Xue; Sébastien Teissier; Françoise Thierry
Journal:  Am J Cancer Res       Date:  2011-01-24       Impact factor: 6.166

6.  A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter.

Authors:  Chen Gao; Ming-Ming Pan; Yan-Jun Lei; Li-Qing Tian; Hui-Ying Jiang; Xiao-Li Li; Qi Shi; Chan Tian; Yu-Kang Yuan; Gui-Xiang Fan; Xiao-Ping Dong
Journal:  BMC Mol Biol       Date:  2012-02-15       Impact factor: 2.946

7.  Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication.

Authors:  Elaine J Gauson; Mary M Donaldson; Edward S Dornan; Xu Wang; Molly Bristol; Jason M Bodily; Iain M Morgan
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

Review 8.  Papillomavirus interaction with cellular chromatin.

Authors:  Jianxin You
Journal:  Biochim Biophys Acta       Date:  2009-09-26

9.  Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes.

Authors:  Vandana Sekhar; Shawna C Reed; Alison A McBride
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

10.  Failure to interact with Brd4 alters the ability of HPV16 E2 to regulate host genome expression and cellular movement.

Authors:  Elaine J Gauson; Xu Wang; Edward S Dornan; Pawel Herzyk; Molly Bristol; Iain M Morgan
Journal:  Virus Res       Date:  2015-09-10       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.